WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 6601 Infant (under 12 months) mortality rate: 982
GDP / capita (US$): 1'2141 Child (under 5 years) mortality rate: 1762

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 14'854  14'417  13'986  13'559  13'138  10'261  7'964  6'735 
Births 705  687  668  650  631  496  384  331 
Surviving infants 643  624  606  587  569  440  333  279 
Pop. less than 5 years 2'865  2'774  2'675  2'592  2'513  1'919  1'468  1'203 
Pop. less than 15 years 7'018  6'783  6'545  6'341  6'135  4'730  3'690  2'927 
Female 15-49 years 3'251  3'164  3'081  2'986  2'895  2'260  1'726  1'513 

Number of reported case

(Click for retrospective incidence data for Mali)
Diphtheria 143 
Japanese encephalitis
Measles 341  24  1'719  2'939  98  1'578  1'388  10'007 
Mumps
Pertussis 41  430  2'811 
Polio* 63  234 
Rubella 19  125  64  33 
Rubella (CRS)
Tetanus (neonatal) 10  11  13  73  203 
Tetanus (total) 108  86  73  11  168  365  294 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Mali)
Vaccine year result method % card seen                                                
BCG 2008  86  EPI   65.0  99*  100  97  81  99*  82  82 
DTP1 2008  85  EPI   65.0  99*  99*  99*  99*  61 
DTP3 2008  75  EPI   65.0  90  88  92  89  99*  54  42 
HepB_BD         
HepB3 2008  75  EPI   65.0  90  88  92  89  99* 
Hib3 2008  75  EPI   65.0  90  88  92  89  99* 
JapEnc         
MCV 2008  71  EPI   65.0  85  82  89  86  97  55  43 
MCV2         
PCV1          99*  99* 
PCV3          87  56 
Pol3 2008  76  EPI   65.0  90  87  89  86  99*  54  42 
Rota1         
Rota_last         
Rubella1         
TT2plus 2008  77  EPI   65.0  66  60  59  61  67  62  37 
PAB         
VAD1         
YFV 2008  74  EPI   65.0  84  81  88  85  94 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Mali)
BCG 89  89  86  86  86  69  82 
DTP1 85  85  85  85  85  61  67 
DTP3 74  72  76  73  74  43  42 
HepB3 74  72  76  73  74 
Hib3 74  72  76  73  74 
MCV 59  56  63  60  71  49  43 
PAB 89  89  85  92  92  50  45 
PCV3 74  56 
Pol3 74  71  73  70  74  53  42 
Rota_last
YFV 64  61  68  65  74  11 

Number of districts in the country 60  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
86 
   
/
|
|
\
Greater or equal to 90% 58
From 80 to 89% 15
From 50 to 79% 7
Less than 50% 13
Proportion of districts
not reporting DTP3 coverage
7
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV Birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus Yes From September 2013
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2007-2011  2007-2011  2007 - 2011  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 60    59  59  59  26   

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No    No         

System performance

Total number of districts in country number 60  60  59  59  59  59  59 
Nº districts with DTP3 coverage >=80% number 44  43  42  48  48  36  42 
% of districts with DTP3 coverage >=80% From 0 to 100% 73  72  71  81  81  61  71 
Nº districts with measles (MCV1) coverage >=95% number 15  10  18  34  36     
% of districts with MCV1 coverage >=95% From 0 to 100% 25  17  31  58  61     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 12    20  100  20  100  77 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No No  No  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.